Lapatinib inhibits stem/progenitor proliferation in preclinical in vitro models of ductal carcinoma in situ (DCIS).

Gillian Farnie, RL Johnson, KE Williams, RB Clarke, Rachael L. Johnson, Kathryn E. Williams, Robert B. Clarke, NJ. Bundred

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)418-425
Number of pages7
JournalCell Cycle
Volume13
Issue number3
Early online date18 Nov 2013
DOIs
Publication statusPublished - Feb 2014

Keywords

  • Cancer stem cells
  • DCIS
  • HER2
  • Lapatinib
  • Proliferation

Cite this